These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 11407343)
1. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343 [TBL] [Abstract][Full Text] [Related]
2. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095 [TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370 [TBL] [Abstract][Full Text] [Related]
4. A molecular basis for Wolff-Parkinson-White syndrome. Basson CT N Engl J Med; 2001 Jun; 344(24):1861-4. PubMed ID: 11407351 [No Abstract] [Full Text] [Related]
5. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome. Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Arad M; Moskowitz IP; Patel VV; Ahmad F; Perez-Atayde AR; Sawyer DB; Walter M; Li GH; Burgon PG; Maguire CT; Stapleton D; Schmitt JP; Guo XX; Pizard A; Kupershmidt S; Roden DM; Berul CI; Seidman CE; Seidman JG Circulation; 2003 Jun; 107(22):2850-6. PubMed ID: 12782567 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829 [TBL] [Abstract][Full Text] [Related]
10. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome. Zhang LP; Hui B; Gao BR J Electrocardiol; 2011; 44(4):483-6. PubMed ID: 20381067 [TBL] [Abstract][Full Text] [Related]
11. A gene responsible for familial Wolff-Parkinson-White syndrome. Anderson KP; Vidaillet HJ; Josephson ME N Engl J Med; 2001 Oct; 345(14):1063-4. PubMed ID: 11586962 [No Abstract] [Full Text] [Related]
12. AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: new perspectives on heart development and arrhythmogenesis. Gollob MH; Roberts R Eur Heart J; 2002 May; 23(9):679-81. PubMed ID: 11977988 [No Abstract] [Full Text] [Related]
13. Electrophysiologic characteristics of accessory atrioventricular connections in an inherited form of Wolff-Parkinson-White syndrome. Mehdirad AA; Fatkin D; DiMarco JP; MacRae CA; Wase A; Seidman JG; Seidman CE; Benson DW J Cardiovasc Electrophysiol; 1999 May; 10(5):629-35. PubMed ID: 10355918 [TBL] [Abstract][Full Text] [Related]
14. [A familial form of conduction defects associated with a PRKAG2 gene mutation]. Pochmalicki G; Genest M; Richard P; Komajda M; Charron P Arch Mal Coeur Vaiss; 2007 Sep; 100(9):760-5. PubMed ID: 18033003 [TBL] [Abstract][Full Text] [Related]
16. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Burwinkel B; Scott JW; Bührer C; van Landeghem FK; Cox GF; Wilson CJ; Grahame Hardie D; Kilimann MW Am J Hum Genet; 2005 Jun; 76(6):1034-49. PubMed ID: 15877279 [TBL] [Abstract][Full Text] [Related]
17. PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Gollob MH; Green MS; Tang AS; Roberts R Curr Opin Cardiol; 2002 May; 17(3):229-34. PubMed ID: 12015471 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447 [TBL] [Abstract][Full Text] [Related]
19. A familial form of conduction defect related to a mutation in the PRKAG2 gene. Charron P; Genest M; Richard P; Komajda M; Pochmalicki G Europace; 2007 Aug; 9(8):597-600. PubMed ID: 17483151 [TBL] [Abstract][Full Text] [Related]
20. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]